acetamiprid - Exposure Details | CTD
Skip navigation

Chemical acetamiprid

These are exposure details associated with the chemical and all of its children.



1–14 of 14 results.
  Reference Exposure Stressor Number of Receptors Receptors Receptor Notes Medium Exposure Marker Marker Level Measurement Statistic Assay Notes Country Outcome Relationship Disease Phenotype
1. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid 0.18 micrograms per liter 95th percentile Japan
2. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid <LOD 25th percentile Japan
3. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid 0.06 micrograms per liter 75th percentile Japan
4. Marfo JT, et al. (2015). acetamiprid 85 Study subjects mix of cases and controls for Neurologic Manifestations (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid Japan positive correlation Neurologic Manifestations
5. Marfo JT, et al. (2015). acetamiprid 85 Study subjects mix of cases and controls for Neurologic Manifestations (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid 6 nanograms per milliliter maximum Japan
6. Marfo JT, et al. (2015). acetamiprid 19 Subjects with disease:Neurologic Manifestations typical symptomatic group urine N-desmethylacetamiprid 6 parts per billion maximum Japan
7. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid <LOD geometric mean Japan
8. Marfo JT, et al. (2015). acetamiprid 50 Controls for disease:Neurologic Manifestations non-symptomatic group urine N-desmethylacetamiprid 2.2 parts per billion maximum Japan
9. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid 0.36 micrograms per liter maximum Japan
10. Marfo JT, et al. (2015). acetamiprid 85 Study subjects mix of cases and controls for Neurologic Manifestations (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid 1.2 nanograms per milliliter median Japan
11. Marfo JT, et al. (2015). acetamiprid 16 Subjects with disease:Neurologic Manifestations atypical symptomatic group urine N-desmethylacetamiprid 4.4 parts per billion maximum Japan
12. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid 0.02 micrograms per liter 50th percentile Japan
13. Marfo JT, et al. (2015). acetamiprid 85 Study subjects mix of cases and controls for Neurologic Manifestations (typical, atypical, and non- symptomatic) urine N-desmethylacetamiprid 0.62 nanograms per milliliter minimum Japan
14. Ueyama J, et al. (2014). acetamiprid 52 Study subjects urine acetamiprid <LOD 5th percentile Japan
1–14 of 14 results.